Home Other Building Blocks 668273-75-4
668273-75-4,MFCD22376710
Catalog No.:AA00FGTK

668273-75-4 | Tert-butyl((3s)-1-(7-(but-2-yn-1-yl)-3-Methyl-1-((4-Methylquinazolin-2-yl)Methyl)-2,6-dioxo-2,3,4,5,6,7-hexahydro-1h-purin-8-yl)piperidin-3-yl)carbaMate

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
97% HPLC
in stock  
$47.00   $33.00
- +
5g
97% HPLC
in stock  
$160.00   $112.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA00FGTK
Chemical Name:
Tert-butyl((3s)-1-(7-(but-2-yn-1-yl)-3-Methyl-1-((4-Methylquinazolin-2-yl)Methyl)-2,6-dioxo-2,3,4,5,6,7-hexahydro-1h-purin-8-yl)piperidin-3-yl)carbaMate
CAS Number:
668273-75-4
Molecular Formula:
C30H36N8O4
Molecular Weight:
572.6580
MDL Number:
MFCD22376710
SMILES:
CC#CCn1c(nc2c1c(=O)n(c(=O)n2C)Cc1nc(C)c2c(n1)cccc2)N1CCCC(C1)NC(=O)OC(C)(C)C
Properties
Computed Properties
 
Complexity:
1100  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Heavy Atom Count:
42  
Hydrogen Bond Acceptor Count:
8  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
7  
XLogP3:
3.6  

Downstream Synthesis Route

[1]CurrentPatentAssignee:SICHUANKELUNPHARMACEUTICALCOMPANYLIMITED-CN106554354,2017,ALocationinpatent:Paragraph0134-0137

[2]CurrentPatentAssignee:LUNANPHARMACEUTICALGROUPCOLTD-CN111574520,2020,ALocationinpatent:Paragraph0173-0175

[3]CurrentPatentAssignee:LUNANPHARMACEUTICALGROUPCOLTD-CN111574463,2020,ALocationinpatent:Paragraph0177-0178

[4]CurrentPatentAssignee:ChifengSailintaiPharmaceuticalCo.,Ltd.;Cui,Yujie;Zhang,Lihua;Zhao,Hongwei;Wang,Yanfeng;Ji,Liping;Sheng,Li;Wang,Jieting;Ma,Zheng-2016Locationinpatent:Paragraph0053;0054;0055;0056

[5]CurrentPatentAssignee:CHIFENGSALIONTPHARMACEUTICAL-CN105936634,2016,ALocationinpatent:Paragraph0123;0124;0125;0126

[6]CurrentPatentAssignee:ChifengSailintaiPharmaceuticalCo.,Ltd.;Cui,Yujie;Zhang,Lihua;Zhao,Hongwei;Wang,Yanfeng;Ji,Liping;Sheng,Li;Wang,Jieting;Ma,Zheng-2016Locationinpatent:Paragraph0053;0054;0055;0056

[7]Eckhardt,Matthias;Langkopf,Elke;Mark,Michael;Tadayyon,Moh;Thomas,Leo;Nar,Herbert;Pfrengle,Waldemar;Guth,Brian;Lotz,Ralf;Sieger,Peter;Fuchs,Holger;Himmelsbach,Frank[JournalofMedicinalChemistry,2007,vol.50,#26,p.6450-6453]

[8]CurrentPatentAssignee:NANJINGJUNRUOBIOMEDICALRESINSTITUTE;HAIMENBAIKANGPHARMACEUTICAL;JIANGSUJUNRUOPHARMACEUTICAL-CN110872292,2020,ALocationinpatent:Paragraph0037-0038

[9]CurrentPatentAssignee:WEIHAIKAIMEIKEMEDICALTECHNOLOGYDEV-CN104844602,2018,BLocationinpatent:Paragraph0045;0046

[10]CurrentPatentAssignee:2YCHEM-US2015/274728,2015,A1Locationinpatent:Paragraph0224-0228

[11]CurrentPatentAssignee:SHANGHAIWONDERPHARMACEUTICALCOLTD-CN105622609,2016,ALocationinpatent:Paragraph0051

[12]CurrentPatentAssignee:SHANGHAIMODERNPHARMACEUTICALCO.,LTD.;CHINANATIONALPHARMACEUTICALGROUPCORPORATION-CN106478629,2017,ALocationinpatent:Paragraph0022-0027

[13]CurrentPatentAssignee:GANLEEPHARMACEUTICALSJIANGSU-CN110964013,2020,ALocationinpatent:Paragraph0033;0041-0043;0044-0065

[14]CurrentPatentAssignee:HEFEIYUANZHIPHARMACEUTICALRD-CN106008508,2016,ALocationinpatent:Paragraph0016;0023;0024;0025;0031;0032

[15]CurrentPatentAssignee:SUNPHARMACEUTICALINDUSTRIESLIMITED-WO2015/11609,2015,A1Locationinpatent:Page/Pagecolumn13

[16]CurrentPatentAssignee:YAMASACORPORATION-JP2020/70296,2020,ALocationinpatent:Paragraph0061-0067

[17]CurrentPatentAssignee:PERMIRAHOLDINGSLIMITED;CAMBREXPROFARMACOMILANOSRL-WO2019/219620,2019,A1Locationinpatent:Page/Pagecolumn12

[18]CurrentPatentAssignee:TEVAPHARMACEUTICALINDUSTRIESLTD.-US2013/123282,2013,A1Locationinpatent:Paragraph0158

[19]CurrentPatentAssignee:ZYDUSLIFESCIENCESLTD-WO2013/171756,2013,A1Locationinpatent:Page/Pagecolumn17

[20]CurrentPatentAssignee:VIATRISINC-WO2014/97314,2014,A1Locationinpatent:Page/Pagecolumn11-12

[21]Lai,Zeng-Wei;Li,Chunhong;Liu,Jun;Kong,Lingyi;Wen,Xiaoan;Sun,Hongbin[EuropeanJournalofMedicinalChemistry,2014,vol.83,p.547-560]

[22]CurrentPatentAssignee:WOCKHARDTLIMITED-WO2015/4599,2015,A1Locationinpatent:Page/Pagecolumn19

[23]CurrentPatentAssignee:ZYDUSLIFESCIENCESLTD-US2015/51228,2015,A1Locationinpatent:Paragraph0141

[24]CurrentPatentAssignee:QILUPHARMACEUTICALGROUPCOLTD-CN105272982,2016,ALocationinpatent:Paragraph0044-0045

[25]CurrentPatentAssignee:BIOCONLIMITED-WO2019/64214,2019,A1Locationinpatent:Page/Pagecolumn10;11

[26]CurrentPatentAssignee:SHENZHENSECONDPEOPLE`SHOSPITAL-CN110590780,2019,ALocationinpatent:Paragraph0052-0056

[27]CurrentPatentAssignee:KYONGBOPHARM-KR2019/124536,2019,ALocationinpatent:Paragraph0048-0051

[28]CurrentPatentAssignee:BEIJINGRONGYINGPHARMACEUTICALTECH-CN110615790,2019,ALocationinpatent:Paragraph0004;0008;0009

[29]CurrentPatentAssignee:YANGTZERIVERPHARMACEUTICALGROUPCOLTD-CN110684026,2020,ALocationinpatent:Paragraph0040;0045-0047;0052-0054;0059;0061;0066-0067

[30]CurrentPatentAssignee:SHANDONGYONGCHENGPHARMACY-CN112724140,2021,ALocationinpatent:Paragraph0041;0048-0059

[31]Wang,Hailong;Chen,Kai;Lin,Biyue;Kou,Jingping;Li,Lijun;Wu,Shuming;Liao,Shouzhu;Sun,Guodong;Pu,Junwen;Yang,Hua;Wang,Zhongqing[OrganicProcessResearchandDevelopment,2022,vol.26,#12,p.3254-3264]

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 668273-75-4
Tags:668273-75-4 Molecular Formula|668273-75-4 MDL|668273-75-4 SMILES|668273-75-4 Tert-butyl((3s)-1-(7-(but-2-yn-1-yl)-3-Methyl-1-((4-Methylquinazolin-2-yl)Methyl)-2,6-dioxo-2,3,4,5,6,7-hexahydro-1h-purin-8-yl)piperidin-3-yl)carbaMate